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ABSTRACT  Cartilage-derived  growth  factor  (CDGF), a cationic  polypeptide  of ~18,000  mol 
wt,  was  prepared  from  bovine  articular  cartilage;  other  sources  were  bovine  and  human 
scapular and costal  cartilage.  Previous  studies have shown that CDGF stimulates the prolifer- 
ation of cultured mouse fibroblasts as well as chondrocytes and endothelial cells from various 
sources.  In this study, CDGF was shown to stimulate dose-dependently the accumulation  of 
DNA and  collagen  by  rat  embryo  fibroblasts  and  a  population  of fibroblasts  derived  from 
granulation tissue.  CDGF also stimulated the proliferation  of cultured  bovine capillary endo- 
thelial cells dose-dependently. To evaluate the effects of CDGF in vivo, we implanted polyvinyl 
alcohol sponges subcutaneously in rats. 6 d postimplantation, sponges were injected with 300 
pg of partially purified CDGF, a dose which takes into account the cell numbers in the sponges 
as compared with cell cultures. CDGF rapidly disappeared from the sponges and only ~10% 
of the initial dose was present at 4 h. Despite  its transient presence,  CDGF caused  a relative 
increase  in  sponge  DNA content of 2.6-fold  at 48 h and  2.4-fold  at  72  h. We  repeated  the 
sponge  experiment  by  using  500-ng  injections  of  CDGF  purified  to  near  homogeneity  by 
heparin-Sepharose  chromatography.  Purified  CDGF  caused  significant  increases  in  sponge 
collagen,  protein,  and  DNA content  at 48 and  72  h after a single  injection.  The effects  of 
CDGF were abolished by heat and unaffected  by reduction of disulfide linkages.  Morpholog- 
ically, CDGF did not evoke an inflammatory response, and its effect on proliferating endothelial 
cells  and fibroblasts  was, therefore,  probably direct.  However,  increases  in  DNA content of 
sponges  could  not be fully accounted  for by increased  DNA synthesis,  which  suggests that 
recruitment  may  be an  important  component  of the  in  vivo  response.  Taken  together,  the 
effects of CDGF on cultured cells  and granulation tissue  suggest that the sustained  presence 
of CDGF in vivo may greatly enhance its effects  upon wound repair. 
A  number of polypeptide growth factors that stimulate the 
proliferation of cells in culture have been described in the last 
decade.  These  include  epidermal  growth  factor,  fibroblast 
growth factor, and platelet-derived growth factor (5,  6,  17). 
Many of the growth factors are large polypeptides that have 
specific receptor-mediated interactions with their target cells, 
and such interactions are associated with cell proliferation in 
vitro. By contrast, the efficacy of growth factors in vivo is not 
nearly so clearly established. This is in part the result of the 
difficulty of administering growth factors and measuring their 
cellular response in vivo. 
The cartilage-derived growth factor (CDGF)' is a cationic 
polypeptide with a  molecular weight of ~ 18,000  which can 
1  Abbreviations used in this paper. BCE, bovine capillary endothelial; 
CDGF, cartilage-derived growth factor; DME, Dulbecco's modified 
Eagle's medium; FCS, fetal calf serum; TCA, trichloroacetic acid. 
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bovine or human sources (3,  12). CDGF is probably related 
to a capillary endothelial cell growth factor derived from a rat 
chondrosarcoma (19). CDGF stimulates the proliferation and 
migration of cultured fibroblasts, chondrocytes, and endothe- 
lial cells (4,  11, 22).  In this paper, we compare the effects of 
CDGF on the proliferation and collagen synthesis of cultured 
fibroblasts with those observed in vivo. We studied the in vivo 
effects by examining the organizational response in subcuta- 
neously implanted polyvinyl alcohol sponges in rats.  In ad- 
dition, the proliferation and motility of endothelial cells stim- 
ulated by CDGF in culture was compared with the induction 
of angiogenesis in sponges in vivo. 
MATERIALS  AND  METHODS 
Preparation  of CDGF lxtracellular Matrix:  The preparation  of 
bovine articular cartilage from the joints of 1-14-d-old calves has been described 
previously (3). For the  preparation  of cartilage extracellular matrix,  cartilage 
was diced finely with  a  scalpel and  resuspended  in  Dulbecco's  phosphate- 
buffered saline (PBS), pH 7.5, that contained 0.2% clostridial collagenase (150 
U/ml, CLS II, Worthington  Biochemical Corp., Freehold, NJ), penicillin (200 
U/ml), and streptomycin (200 #g/ml).  The cartilage was digested in a capped 
sterile tube for 16-18 h at 37"C with constant agitation. The digest was passed 
through a 153-#m nylon sieve (HC3-110, Tetko, Inc., Elmsford, NY) to remove 
debris and undigested material. Chondrocytes were removed from the filtered 
digest by sedimentation  at  1,000 g for  10  min.  The supernatant,  which was 
designated as the cartilage matrix digest, was sterilized by filtration through a 
0.45-~m filter (Nalgene, Rochester, NY). The cartilage matrix digest contains 
mostly protein and proteoglycan at a concentration  of ~25 mg/ml, For short- 
term storage (_<1 mo), the cartilage matrix digest was stored frozen at -20"C. 
For long-term  storage, the cartilage matrix  digest was dialyzed against three 
changes of  distilled deionized water (Spectrophor tubing, 6,000-8,000 Mr cutoff, 
Fisher Scientific Co., Pittsburgh,  PA), lyophilized, and stored as a powder at 
-20°C. 
Ion Exchange  Chromatography:  Cartilage  matrix digest was par- 
tially purified  by  cation  exchange chromatography  on  Bio-rex 70  (200-400 
mesh, Bio-Rad Laboratories, Richmond,  CA). Columns (2 x 9 era, 28 ml bed 
vol) were equilibrated with 0.1 M NaC1 and 0.01 M Tris-HCI, pH 7.0, at a flow 
rate of -20 ml/h. Samples were applied to the column in one of two ways. In 
the first, 50 ml of frozen cartilage matrix digest was thawed and mixed with 50 
ml of  the equilibration buffer. The sample was then filtered through a 0.45-~m 
Nalgene fl)ter and  applied  to the  column.  Alternatively,  1 g of lyophilized 
cartilage  matrix  digest was resuspended  in  100  ml  of equilibration  buffer, 
filtered with a 0.45-~m Nalgene filter, and applied to the column. After sample 
loading, the  column was washed with 90  ml of equilibration  buffer. Bound 
material was eluted with a gradient of 0.1-1  M NaCI in 0.01 M Tris-HC1, pH 
7.0, in  140  ml.  8-ml fractions were collected and monitored  for absorbance 
with a Gilford 2400-S spectrophotometer  280 nm (Gilford Instruments Labo- 
ratory, Inc.. Oberlin. OH), for conductivity  with a radiometer  (Rainin  Instru- 
ment Co., Woburm MA), and for the ability to stimulate  DNA synthesis in 
BALB/c 3T3 cells. The material  from this procedure was designated partially 
purified CDGF. 
Heparin-Sepharose Chromatography:  Crude growth factor was 
prepared by extraction of  bovine scapular cartilage with 1 M guanidine chloride 
as described previously (12). An extract (30 g/700  ml) was resuspended in a 
column buffer of 0.1  M NaC1 and 0.01 M Tris HC1, pH 7.5. The sample was 
divided in half, and each half was applied at 4"C to a column ( 160 ml bed vol) 
of heparin-Sepharose (Pharmacia  Fine Chemicals, Piscataway, N  J) at a flow 
rate of 60 ml/h. The columns were washed first with 0.15 M NaCI and 0,01 M 
Tris, pH 7.5 (1,300 ml) and then with 0.5  M NaCI and 0.01 M Tris, pH 7.5 
(600 ml). Growth factor was eluted from both columns by batch elution with 
2.5 M NaCI and 0.01 M Tris, pH 7.5 (l,000  ml). The two 0.5 M-3.0 M NaCl 
fractions were pooled and dialyzed exhaustively against 0.1  M NaCl and 0.01 
M Tris,  pH  7.5  (three  changes,  48  h,  Spectrophor  tubing,  6,000-8,000  Mr 
cutoff, Fisher Scientific Co.). About 400,000 U (in -2,000 ml) of growth factor 
activity were recovered from the two columns and applied to another 160-ml 
heparin-Sepharose column.  After a wash with 0.6 M NaCI and 0.01 M Tris, 
pH 7.5, growth factor was eluted with a  1,500 ml gradient of 0.6-3.0  M NaC1 
at  a  flow rate  of 50  ml/h. 8-ml  fractions  were collected and growth  factor 
activity was determined,  as measured  by testing for the ability of fractions to 
stimulate  DNA synthesis in  3T3  cells. The concentration  of NaC1 in  each 
fraction of the gradient was determined with a conductivity meter (radiometer). 
The material from this preparation was designated purified CDGF. 
SDS PACE:  CDGF was analyzed by SDS PAGE (13). The polyacryl- 
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amide  gels were developed with silver stain  (15). Molecular weight markers 
were purchased from Bio-Rad Laboratories and from Bethesda Research Lab- 
oratories. 
Size Exclusion Chromatography:  CDOF  (14,000  U/2.5 ml), pu- 
rified by heparin-Sepharose chromatography,  was applied to an ACA 54 (LKB 
Instruments,  Inc., Gaithersburg,  MD) size-exclusion column (1.6 x  100 cm) 
equilibrated with 0.5  M NaCI, 0.01 M Tris HCI, pH 7.5. Growth factor was 
eluted at a flow rate of 6 ml/h, and fractions (2.8 ml) were collected and tested 
for the  ability  to  stimulate  DNA synthesis  in  3T3  cells. The column was 
calibrated  with  the  molecular  weight markers  serum albumin  (Mr 68,000), 
myoglobin (M~ 17,800), and ribonuclease (Mr 13,700). 
Assay of DNA Synthesis  in 3"13 Ceils:  The growth of BALB/c 
3T3 cells, the preparation of  confluent, quiescent 3T3 cells in 96-well microtiter 
plates (Costar Corp.,  Cambridge,  MA), and the methods  for measuring the 
incorporation  of methyl-[3H]thymidine into DNA  have been  previously de- 
scribed (11). In brief, a  microtiter  plate that contained  ~2  x  104 confluent, 
quiescent  BALB/c  3T3  cells per microtiter  well was prepared.  The CDGF 
sample and [3H]thymidine (4 ~Ci/ml)  were added,  and the incorporation  of 
[3H]thymidine into  DNA  was measured  after  a  36-48-h  incubation.  In the 
bioassay, background incorporation was typically 200-1,000 cpm, and maximal 
incorporation  was ~ 100,000-120,000 cpm. A unit of growth factor activity is 
defined as the amount of growth factor required to half-maximally stimulate 
incorporation  of [3H]thymidine (~50,000-60,000  cpm) into the DNA of 104 
3T3 cells. 
Assay of  Capillary  Endothelial  Cell  Proliferation:  Bovine 
capillary endothelial (BCE) cells were prepared from adrenal glands as described 
by  Folkman  et  al.  (4). BCE  cells were  grown  and  maintained  in  tumor- 
conditioned  medium,  which we prepared  by incubating  mouse sarcoma  180 
cultures for 48 h in Dulbecco's modified Eagle's (DME) medium supplemented 
with  10% calf serum and diluting culture supernatants  with an equal volume 
of fresh DME +  1% calf serum.  BCE cell proliferation  was measured  in 24- 
well microtiter plates ( 16-mm diam microtiter wells, Costar Corp.). The tumor- 
conditioned  medium was removed, and the cells were trypsinized, resuspended 
in  fresh DME  +  10%  calf serum,  and plated  sparsely into  microtiter  wells 
(10,000 cells/well). The next day, the  medium  (0.5 ml) that  contained  unat- 
tached cells was removed, and the attached cells were fed with fresh DME + 
10% calf serum to which growth factor preparations  had been added. After a 
72-h incubation  at 37°C, the cells were detached from the microtiter well with 
0.5% trypsin and 0.2% EDTA and counted  in a particle counter  (model Zf, 
Coulter Electronics. Inc., Hialeah, FL). 
Assay of Cell Proliferation and Collagen Synthesis in CDGF- 
stimulated Rat Fibroblasts:  Confluent cultures of rat embryo fibro- 
blasts (provided by F. O'Neill,  Veterans Administration  Medical Center, Salt 
Lake City, UT) were trypsinized and replated at low density ( 10,000 cell~/wefl) 
on 24-well Costar culture dishes in DME that contained  10% fetal calf serum 
(FCS) to compare the effects of CDGF on rat fibroblasts with those observed 
with 3T3 cells. After overnight incubation to allow attachment,  cell layers were 
rinsed with PBS and re-fed with DME that contained 0.5% FCS and 0-32 #g/ 
ml  CDGF.  Positive-control  wells that  contained  5  or  10%  FCS  were also 
included.  Incubation  was continued  for  72  h  in these conditions,  and  then 
these media were removed by aspiration  and replaced with labeling medium 
that contained  0.5% dialyzed FCS, ascorbic acid (50 ~g/ml),/3-aminoproprio- 
nitrile (64 ~g/ml), and [3H]proline (translation  grade, 20 ~Ci/mM,  New Eng- 
land Nuclear,  Boston. MA). After incubation  for 3 h, media were harvested, 
clarified  by  centrifugation,  and  precipitated  with  10%  trichloroacetic  acid 
(TCA). Residual TCA was removed  from the  40,000 g pellets by successive 
washes with ethanol and ether. TCA-insoluble proteins were dissolved in 0.05 
M NaOH, neutralized, and subjected to digestion with purified bacterial colla- 
genase (Form III, Advance Biofactures. Lynnbrook, NY) by the use of standard 
methodologies  (16) as  described  below. Cell layers were  rinsed  with  PBS, 
dissolved  in  0.05 M  NaOH,  and  assayed  for  DNA  content  by  use  of a 
fluorometric  assay (8). Data  were obtained  from duplicate  experiments  with 
triplicate test conditions. 
In  a  second  set  of experiments,  fibroblasts  were  isolated from  sponge 
granulation  tissue, prepared as described below, on the sixth day after sponge 
implantation.  Sponges were dissected free of adventitious tissue, washed in PBS 
containing antibiotics (penicillin,  1,000 U/ml; streptomycin sulfate, 1,000 ug/ 
ml; fungizone, 0.25 ug/ml),  minced, and incubated in DME that contained  1 
mg/ml collagenase (CLSPA, Worthington  Biochemical Corp.) and antibiotics 
for 3 h at 37"C. Cells were dislodged by  repeated  aspiration  with a  Pasteur 
pipette.  Sponge material  was allowed to settle, and cells were decanted  and 
collected  by  centrifugation.  The  cell pellet  was resuspended  in  DME  that 
contained  10% FCS and seeded onto culture flasks. Secondary cultures, which 
had the morphology of fibroblasts, were derived by trypsinization at confluence 
and were then used to seed 24-well dishes with 104 cells/well as described above. 
After exposure to varying concentrations  of purified CDGF in 0,5% FCS, cell 
layers were analyzed for DNA accumulation  (9). Assay of Fibroplasia, Protein Synthesis, and Collagen Prolif- 
eration in Sponge Implants In Vivo:  sponge  implants  were placed 
beneath the ventral panniculus carnosus of 200-g rats by a standard  technique 
using 9 × 2 mm polyvinyl sponge disks (20). Each animal was implanted  with 
four sterile sponges, and analysis of  each experimental condition was performed 
on three identically treated sponges from individual rats. 6 d after implantation, 
one set of animals was killed by ether anesthesia and the sponges were removed 
for determination  of  base-line conditions. Three sets of  experimental conditions 
were used: (a) sponges were injected with 0. l  ml of partially purified CDGF 
(150 U; 300 #g) or purified CDGF (150 U) in 0.9% saline; (b) sponges in the 
same animal  received an injection  of 0.9% saline alone;  and (c) uninjected 
sponges were maintained  in rats that received no CDGF. Experimental animals 
were sacrificed 0, 48, and 72 h after injection. Implanted sponges were dissected 
free of loosely adherent  fat and muscle and placed into DME that contained 
antibiotics (penicillin,  1,000 U/ml, and streptomycin,  1,000 #g/ml) and  10% 
FCS. 
For evaluation of  collagen and protein synthetic activity, sponges were finely 
minced  and cultivated  in a gyrotory water bath  at 37°C in  3 ml DME  that 
contained  [3H]proline (30 t~Ci/ml),/~-aminoproprionitrile (64 #g/ml), ascorbic 
acid  (50  #g/ml),  1%  dialyzed  FCS, and  a  10-fold lower  concentration  of 
antibiotics  than described above.  At the end  of the  incubation,  the  minced 
tissue was rinsed with ice cold PBS that contained  1 mg/ml unlabeled proline 
and homogenized in 0.5 M acetic acid that contained  pepstatin (l #g/ml) and 
N-ethyl maleimide  (10 mM) to inhibit  acid  proteases. The  homogenate  was 
extracted overnight at 4°C, and aliquots were removed for amino acid analysis 
and DNA determination.  The homogenate was then clarified by centrifugation 
08,000 g, 4°C, 20 min), and the supernatant  was precipitated with  10% TCA 
for collagenase digestion (16) as described above, 
Relative collagen synthesis was quantified  as the amount of radioactivity 
released into TCA-soluble material after limited digestion with highly purified 
bacterial  collagenase. Each  sample  was corrected  for nonspecific  release of 
radioactivity in blanks incubated without enzyme. Percentage collagen synthesis 
was corrected  for the over-representation  of amino acids in the protein  (16). 
Collagen content was determined  by amino acid analysis of hydrolyzed (18 h, 
110°C) sponge under the assumption that the average collagen molecule con- 
tained  10% hydroxyproline  residues. DNA content  of sponges was measured 
in homogenates by use of the fluorometric assay described above (8). 
Assay of DNA Synthesis in  Granulation  Tissue:  Implanted 
sponges (four per animal)  were injected on day 4 with  150 U  of partially 
purified CDGF (n = 2), saline, or nothing. Rats were injected intraperitoneally 
with methyl-[3H]thymidine (250 #Ci) 6 h before they were killed. Animals were 
sampled 6, 24, 48, and 72 h after the initial CDGF injection. For the determi- 
nation  of the  proportion  of newly synthesized DNA in granulation  tissue in 
vivo, labeled sponges were rinsed, homogenized in 0.1  M NaOH, and extracted 
overnight at 4"C. Aliquots were taken for fluorimetric determination  of DNA 
content,  TCA-precipitable  radioactivity, and TCA-soluble disintegrations  per 
minute. Total uptake per sponge, uptake per milligram wet weight, incorpora- 
tion per sponge, and incorporation  per microgram DNA were determined.  To 
correct for animal  variability, all data  were expressed as the ratios of CDGF- 
injected to matched control values. 
Measurement of the Disappearance of CDGF from Sponge 
Implants:  ~251-CDGF  (10 ug) was prepared  with  Bolton-Hunter  reagent 
(4,000 Ci/mmol, New England Nuclear) according to manufacturer's  instruc- 
tions,  and  had  an  initial  specific activity  of 3  x  l0  ~ cpm/tzg. The  rate  of 
disappearance of CDGF when injected into implanted  sponge granulomas was 
measured by injection of 0.1  ml J251-CDGF  (3 x  103 cpm) into 6-d-old sponge 
implants  (two per animal),  and removal of four sponges immediately  and at 
0.5, 4, 24, 48 and 72 h. Sponges were dissolved in l ml NCS (Amersham Corp., 
Arlington Heights, IL), and radioactivity was quantitated  by liquid scintillation 
counting• 
Histological  Examination of Sponge Granulomas:  At least 
two sponge implants  from each time period and experimental  condition  were 
dissected free of adherent  tissue and  bisected perpendicularly.  Half of each 
sponge was fixed in formalin  and processed for light microscopy. The other 
half was fixed in  Karnovsky's  fixative (10), embedded  in  Spurr resin, thick 
sectioned ( 1 um), and stained with toluidine blue. 
RESULTS  AND  DISCUSSION 
Isolation and Purification of CDGF Activity 
Fig. 1 shows isolation of partially purified CDGF by use of 
Bio-rex 70 resin. With this procedure, it was possible to isolate 
a  protein  fraction that  had  strong positive effects on DNA 
synthesis in 3T3 cells, and to separate this material from low 
molecular weight proteins with few or no such effects. How- 
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FIGURE  1  Cation exchange chromatography of CDGF from bovine 
articular cartilage. Cartilage matrix, ~1.25 g, was prepared by col- 
lagenase digestion. The sample was diluted with an equal volume 
of equilibration buffer (0.1  M  NaCI, 0.01  M  Tris-HCI, pH  7.0) and 
applied to  a  2  x  9  cm  column  of  Bio-rex  70.  The  column  was 
washed with equilibration buffer. Growth factor was eluted from 
the column with a gradient of 0.1  to  1.0 M  NaCI  in equilibration 
buffer. Activity was measured by the ability of fractions to stimulate 
DNA synthesis in BALB/c 3T3 cells. 
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ever,  SDS  PAGE  indicated  that several polypeptide species 
were present (data not shown). As measured by absorbance 
at 280 nm, the protein that co-eluted with CDGF represents 
a  minor fraction of the total protein in the cartilage matrix 
preparation. 
To demonstrate that a unique fraction of cartilage matrix 
was responsible for biological activity, we used heparin-Seph- 
arose chromatography to purify CDGF. A growth factor from 
rat chondrosarcoma was recently isolated by this procedure 
(19). 
When extracts of bovine cartilage were applied to a column 
of  heparin-Sepharose,  growth  factor  bound  tightly  to  the 
column and was eluted with  1.6-1.8  M  NAG1. (Sullivan, R., 
and M. Klagsbrun, manuscript in preparation.) A high degree 
of purification was obtained by use of two cycles of heparin- 
Sepharose chromatography. In the first  cycle,  crude extract 
was applied to the column and after a wash with 0.5 M NAG1, 
CDGF was eluted with 2.5  M  NaCi.  Much more than 99% 
of the contaminating material was removed (data not shown). 
This preparation of CDGF was applied to a second heparin- 
Sepharose column and, after binding, was eluted with a NaC1 
gradient as shown in Fig. 2. SDS PAGE analysis of the highly 
purified CDGF preparation is shown in Fig.  3 (lane 1). Only 
a few bands are present. The predominant band is a doublet 
with  molecular weights of -  18,000-19,000.  The  molecular 
weight of the doublet corresponded closely with the molecular 
weight of CDGF activity found after size-exclusion chroma- 
tography (Fig. 4). It is possible that both bands in the doublet 
are  forms  of CDGF.  Doublets  have  been  found  after the 
purification of platelet-derived growth factor (1) and fibroblast 
growth factor (6), and it has been suggested that these are due 
to processing, proteolytic cleavage that occurs during purifi- 
cation, or different primary structure. Highly purified CDGF 
stimulated half-maximal DNA synthesis (1  U  of activity) at 
concentrations of ~ 10-15  ng/ml (Fig.  5). CDGF stimulated 
not only 3T3 cell proliferation but chondrocyte (1 l) prolifer- 
ation as well. 
The experiments described below indicate that both types 
of CDGF preparations elicited similar biological responses. 
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FIGURE  2  Affinity  chromatography of  CDGF  on  heparin-Sepha- 
rose. About 30 g crude bovine scapular cartilage extract was applied 
to a column of heparin-Sepharose.  After washes in 0.15 and 0.5 M 
NaCI, CDGF  was eluted by batch with 2.5  M  NaCI  (not shown). 
About 400,000 U CDGF activity was applied to another column of 
heparin-Sepharose.  After  a  wash  with  0.15  M  NaCI,  CDGF  was 
eluted with a gradient of 0.6 to 3.0 M NaCI. Fractions were collected 
and tested for the ability of samples to stimulate DNA synthesis in 
3T3 cells, o, [SH]thymidine incorporation into DNA. eeeee,  con- 
ductivity or molarity of NaCI. 
FIGURE  3  SDS  PAGE of CDGF.  The peak of 
CDGF  activity shown in  Fig. 2 (~700 U,  200 
ng) was analyzed by SDS  PAGE. The polya- 
crylamide gel slab was stained  with a  silver 
stain. Lane 1, CDGF; lane 2, molecular weight 
markers  (Bethesda  Research  Laboratories); 
lane  3,  molecular weight  markers  (Bio-Rad 
Laboratories).  KD, kilodaltons. 
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FIGURE  4  Size-exclusion  chroma- 
tography of CDGF.  CDGF  (14,000 
U)  purified by chromatography on 
heparin-Sepharose as described in 
Fig. 2 was applied to a size-exclu- 
sion  column of ACA  54.  Fractions 
were collected and tested for the 
ability to stimulate DNA  synthesis 
in  3T3  cells.  Molecular  weight 
markers  were  serum  albumin 
(67,000),  myoglobin  (17,800),  and 
ribonuclease (13,700). 
Effects of CDGF on Cell Proliferation and 
Collagen Synthesis in Rat Fibroblasts 
The continuous presence of 0.5-32 ~g/ml of partially pu- 
rified CDGF stimulated serum-starved fibroblasts to prolif- 
erate, as measured by DNA production (data not shown). The 
effect at the lowest dose tested was less than that seen with 
0.5%  FCS,  but the effect at the  higher doses exceeded that 
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produced by 5% FCS in stimulating mitosis. Highly purified 
CDGF  prepared  by  heparin  affinity  chromatography  was 
tested on fibroblasts derived from granulation tissue on day 6 
after implantation (Fig. 6). 
Partially purified CDGF stimulated collagen synthesis, ex- 
pressed  as  the  percentage  of total  protein  synthesis,  in  rat 
embryo fibroblasts in a dose-dependent manner (Fig. 7). At a 
concentration of 1 #g/ml per  104 cells,  the percent collagen 
synthesis was increased at least threefold over serum-starved 
controls. At 4 ug/ml per l04 cells, percentage collagen synthe- 
sis was almost 50% greater than that observed with 5% FCS. 
Similar increases in percentage collagen were observed in the 
cell layer; however, this response reached a maximum at  16 
ug/ml of CDGF (not shown). 
The absolute rate of collagen synthesis was not determined 
in these experiments. Since noncollagen protein synthesis may 
have been decreased, it was not proven that CDGF exerted a 
specific effect on  collagen  biosynthesis.  In  other  fibroblast 
cultures, the level of type I collagen mRNA is known to vary 
as  a  function  of the  rate  of proliferation  (20),  so  that  the 
relative increase in  collagen synthesis may be secondary to 
the mitogenic activity of CDGF. 
When  these  positive  in  vitro  effects  of CDGF  on  cell 
proliferation and collagen synthesis are compared with the in 
vivo results, it should be recognized that these effects resulted 
from continuous  exposure of the  fibroblasts to  CDGF.  By 
contrast, in the in vivo studies described below, the exposure 
of maturing granulation tissue to CDGF was transient rather 
than continuous. 
Effects of CDGF on BCE Cell Proliferation 
Fig.  8  shows  the  positive dose response of BCE  cells  to 
partially purified CDGF. The doses used extended to levels 
more than  10-fold higher than those used in the rat embryo 
fibroblast studies, Under conditions of continuous exposure, 
the  positive effect on  BCE cell proliferation was obviously 
more pronounced in the range of 5-20 ~tg/ml than at higher 
doses.  Migration of endothelial cells was previously shown to 
be stimulated by partially purified CDGF (22). 
Effects of CDGF on Sponge  Implants 
Preliminary experiments showed that the maximal effects 
on  DNA  content  of a  single  injection  of partially purified 
CDGF into 6-d-old sponge implants was obtained more than 
24 h after the injection (data not shown). Thus, sampling at 
48 and 72 h was used. Dosage was based on the results of cell 
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FIGURE  7  Collagen synthesis  as a percentage  of total protein syn- 
thesis in rat embryo  fibroblasts exposed  to partially  purified CDGF 
and FCS.  Data are means _+ SE for triplicate determinations  in two 
sets of experiments.  The effect of CDGF at concentrations of 2 #g] 
ml or greater exceeds that of 5% FCS. 
culture  studies  on  3T3  cells  and  rat  fibroblasts  described 
above.  Each  injected  sponge  received  -0.5  #g CDGF  (1  U) 
per 10,000 cells present within it on day 6 after implantation. 
The transient nature of the stimulus provided by injected 
CDGF  is illustrated  in  Fig.  9,  which  shows that  ]25I-CDGF 
rapidly disappeared  from its injection site, the interior of the 
sponge. By 4  h postinjection,  only ~ 10%  of the initial radio- 
activity of '25I-CDGF could be recovered from the injection 
site. Thus, the exposure of the granulation tissue to the factor 
was transient,  in contrast to the continuously exposed  fibro- 
blasts,  3T3 cells, and endothelial cells in culture. Continuous 
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FIGURE  8  Stimulation of capillary endothelial cell proliferation  by 
partially  purified  CDGF.  CDGF  was resuspended  in DME  supple- 
mented  with  10% calf serum and added at various concentrations 
to  bovine  capillary  endothelial  cells.  After  72  h,  the  cells  were 
detached with trypsin-EDTA and counted  in a Coulter counter. 
release  of CDGF  in  vivo  may  be  accomplished  by  using 
microencapsulation, incorporation into ethylene vinyl acetate 
polymer pellets (14), or microdiffusion pumps. 
BIOCHEMICAL  EFFECTS:  Partially  purified  CDGF  ac- 
celerated the development of granulation tissue at the site of 
injection.  At 48  and 72  h, the DNA content of test sponges 
was  increased  more  than  twofold  over  uninjected  control 
sponges  (Table  I).  The  slightly  increased  DNA  content  of 
sponges  that  were  injected  with  saline  as  compared  with 
uninjected sponges probably reflected a nonspecific, mechan- 
DAVIDSON  ET  AL.  Ef[eCt5 of Cartilage-derived  Growth  Factor  1223 ical effect of  the injection. Collagen content showed a transient 
increase, but relative collagen synthesis was not affected. DNA 
content did not increase between 48 and 72 h in test sponges, 
which suggested that a maximum effect on the mitosis and 
recruitment of fibroblasts, the principal cellular constituent 
of the granulomas, was reached by 48 h. 
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FIGURE  9  Disappearance  of  ~251-CDGF from  the  injection  site 
within granulation tissue containing sponges, At 4 h and later, <1 0% 
injected CDGF is recoverable from the sponge. Regression line was 
computer generated, 
To rule out the effects of contaminating activities, a second 
experiment  was  performed  with  purified  CDGF  (150  U/ 
sponge). Fig.  10 illustrates the stimulation of DNA, protein, 
and  collagen  accumulation  in  CDGF-injected  sponges  as 
compared with saline-injected controls. As discussed below, 
the increases in cell number (DNA) and protein content were 
unlikely to be the result of transient inflammatory response, 
since these effects were maximal 3 d after injection and not 
accompanied by any histologic evidence of an inflammatory 
TABLE  I 
Effects of Partially  Purified CDGF on Granulation Tissue 
Collagen  Collagen 
Time*  Injection  +  DNA  s  synthesis  I  content  s 
0  None  32.3 4- 2.5  5.7 +  0.7  492 4- 80 
48  None  44.5 _+ 4.5  11.1 +  0.9  491  4- 38 
48  Saline  57.4 +  14.1  8.4 +  0.9  468 +  103 
48  CDGF  113.9___6.5  6.3+0.7  643+136 
72  None  44.3 +  4.5  6.4 4- 1.3  1,187  +  220 
72  Saline  60.6 ___ 8.3  6.3 +  1.7  887 _+ 118 
72  CDGF  107 _+ 7.7  5.4 +  0.7  757 __ 103 
* Sponges  were implanted 6 d before experiment. Time is expressed  in hours 
after initiation of experiment. 
+ Sponges were  uninjected  (None), injected  with  100  /.d  of sterile saline 
(Saline), or injected with  150 U (300/~g) of partially purified CDGF (CDGF). 
s Expressed  as micrograms per sponge. 
=  Expressed  as percent of total protein synthesis. 
Expressed  as micrograms per sponge as based on hydroxyproline content. 
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FIGURE  10  Biochemical  effects  of  purified 
CDGF on sponge granulation tissue. Sponges 
were injected with  100/~1 of test solution on 
day 6 after implantation and removed imme- 
diately (time 0), or 48 (time 48),  or 72 h (time 
72) after injection. Sponges were analyzed for 
DNA, total protein, or total collagen content, 
expressed  per  milligram  wet  weight,  as  de- 
scribed in the text. CDGF-derived results are 
shown in dark bars as either untreated (native), 
reduced (5 mM dithiothreitol), heat denatured 
(heated),  or multiply injected. Error  bars  rep- 
resent SEM, and statistical significance (t-test) 
is shown by asterisks  (L P< 0.05; **, P< 0.01; 
***,  P <  0.001).  [~,  base  line;  I,  CDGF;  I-], 
saline. infiltrate. Repeated daily injections of CDGF were less effec- 
tive in causing the increase in granulation tissue cellularity. 
To help exclude the possibility that CDGF was a homologue 
of other,  well-known growth  factors,  we used  reduction  (5 
mM dithiothreitol) and heat denaturation (98"C,  10 min) as 
controls. Whereas the presence of dithiothreitol (Fig.  10) did 
reduce the accumulation of DNA in both control and treated 
sponges, reduced CDGF was still an effective stimulus when 
compared with 0.5  mM dithiothreitol in saline.  Heat dena- 
turation  abolished  the  activity  of CDGF.  Taken  together, 
these results showed that CDGF did  not  resemble platelet- 
derived growth factor, which is sensitive to reduction (1) and 
is heat stable (2). However, like CDGF (3), fibroblast growth 
factor is  resistant  to  reduction  and  is  heat  labile (2,  5).  A 
detailed structural comparison of pure CDGF and fibroblast 
growth factor will be necessary to ascertain whether there is a 
relationship between these polypeptides. 
The first set of experiments with partially purified CDGF 
showed only a  moderate and  transient  increase in  collagen 
content, which was not attributable to an increased relative 
synthesis (Table I). However, collagen accumulation was sig- 
nificantly accelerated at 48 and 72 h by a single injection of 
purified  CDGF  (Fig.  I0).  The  relationship  between  these 
results obtained in vivo and our findings in vitro ofa CDGF- 
induced increase in  relative collagen synthesis (Fig.  7)  have 
several potential explanations:  (a) the transient  presence of 
CDGF in the sponges as opposed to its continuous presence 
in  cell  culture;  (b)  the  nature  of the  target  cells;  (c)  the 
differences  in  cell  density  and  arrangement;  and  (d)  the 
possible production of collagenases by the invasion of capil- 
laries,  fibroblasts, and other cells of granulation tissue. 
More prolonged exposure of granulation tissue to CDGF 
by a method less traumatizing than injection might elicit data 
more concordant with those illustrated for rat embryo fibro- 
blasts. However, the mechanism of growth factor action may 
be  to  increase  the  number  of collagen-producing  cells  by 
proliferation or recruitment. Granulation tissue is populated 
by several cell types, including capillary endothelium, which 
is  specifically stimulated  to  grow  and  migrate  in  vitro  by 
CDGF (22).  The production of collagenase is reported to be 
stimulated  in  capillary  endothelial  cells  by  tumor-derived 
mitogens (7). Thus, the aspects of tissue remodeling and cell- 
cell  interaction  may be  important  differences between  the 
mode of CDGF action in vivo and in vitro. 
MORPHOLOGIC  EFFECTS:  The morphological effects of 
CDGF illustrated in  Figs.  11-13  included an increased vas- 
cular response to CDGF. This was most pronounced at the 
periphery  of the  sponge  and  in  the  immediately adjacent 
connective tissue.  Capillaries and  precapillary arterioles  in 
CDGF-injected sponges were both more numerous and more 
widely dilated than in controls at these sites at 48 and 72 h 
(Fig.  12). The  extent  of  organization  in  CDGF-injected 
sponges exceeded that in controls at 48  and 72 h.  By 72 h, 
CDGF sponges were infiltrated more than 75% with connec- 
tive tissue,  whereas controls were infiltrated  less  than  50% 
(Fig.  11, a, b), and the granulation tissue deep within CDGF 
sponges contained  more numerous capillaries than  did  the 
corresponding connective tissue in controls (Fig.  11 c). 
FIGURE  11  Organization of granulation tissue. Transverse sections 
of sponge implants 72 h postinlection, dorsal surface left, are shown. 
(a) Local control. Granulation tissue has penetrated to the level of 
arrowheads. Fibrin and small numbers of erythrocytes are present 
in the center of the sponge. (b) CDGF-injected sponge. Connective 
tissue has extended to zone marked by arrowheads and occupies 
all except a small central zone. Hematoxylin-eosin stain was used. 
x  40.  (c)  CDGF-inlected  sponge  showing  more  numerous  and 
conspicuous  small  capillaries  than  in  controls  (arrowheads).  He- 
matoxylin-eosin stain was used. x  100. 
DAVIDSON ET AL.  Effects of Cartilage-derived  Growth  Factor  1225 FIGURE 12  Morphology of sponge granulation tissue. Granulation 
tissue adjacent to ventral surface of sponges, 72 h postinjection. (a) 
Local control. (b) CDGF-injected sponge. Note that there are cap- 
illaries and marked dilatation of capillaries in b  (arrowheads).  He- 
matoxylin-eosin stain was used. x  400. 
Although  CDGF  accelerated  the  organization  of  the 
sponges at 48  and  72  h,  it did  not  incite an inflammatory 
response; the cellular constituents of both CDGF-injected and 
control  sponges  consisted  almost exclusively of fibroblasts 
and capillaries; and only occasional monocytes and plasma 
cells could be found (Fig.  13, a and b). Multinucleated giant 
cells were usually present adjacent to the sponge matrix by 72 
h in all sponges. The greater degree of organization of CDGF 
sponges than of controls at 48 and 72 h confirms the observed 
increase in DNA, protein, and collagen content. 
The morphological response to highly purified CDGF was 
not different from that seen with the less characterized mate- 
rial.  CDGF-induced neovascularization and organization of 
the  sponges  was  most  pronounced  in  72-h  and  multiple- 
injection sponges. Its effects were less pronounced and about 
equal in 48-h and dithiothreitol-injected sponges. Again, no 
CDGF-induced inflammatory response was noted. 
Recruitment  versus Proliferation 
Whereas CDGF had clear-cut mitogenic properties in vitro, 
the increased content of cells and matrix in granulation tissue 
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FIGURE 13  Cellular  constituents  of  granulation  tissue  within 
sponges. Tissue was removed and fixed 72 h postinjection. (a and 
b) 1  -#M sections of control (a) and CDGF injected sponge (b). Note 
the absence of an inflammatory response. Capillaries (C) and fibro- 
blasts (,) are principal constituents. Fibroblasts are more elongated 
and more densely packed in CDGF than in control sponges. Tolui- 
dine blue was the stain used. x  600. 
could  have been  the  result  of other response  mechanisms. 
Another cationic polypeptide growth factor, platelet-derived 
growth factor, is known to have potent chemoattractant prop- 
erties (2,  18). To evaluate the relative contribution of ingres- 
sion and local proliferation of cells, we determined the extent 
of total uptake, total incorporation, and thymidine incorpo- 
ration per microgram DNA at several intervals after injection 
of CDGF on day 4. 
The results of this experiment are displayed in Fig.  14 as 
the ratios of  experimental to control values at each time point. 
Thus, a ratio for incorporation per microgram DNA less than 
1 signifies dilution of the total DNA pool of the sponge with 
unlabeled DNA. Although thymidine uptake, uptake per wet 
weight, and total incorporation per sponge were all somewhat 
elevated above control values, the key parameter of incorpo- q~15 
uptake,dpm  C~,.=~ 
-" 
~  0.8 "dpm/.g DNA 
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FIGURE 14  Effect  of CDGF on in vivo recruitment and prolifera- 
tion.  Data are expressed as the  ratio of experimental to control 
(saline-injected) value. Identity with controls produced a value of 
1.0. CDGF or saline was injected on day 4. For each determination, 
250 ~Ci  methyl-[3H]thymidine was  injected  intraperitoneally 6  h 
before the indicated time to evaluate DNA synthesis.  Total thymi- 
dine uptake (O), thymidine uptake per milligram wet weight (@), 
and total thymidine incorporation per sponge (A) were somewhat 
elevated above controls,  more so at early time points.  However, 
incorporation per microgram  DNA (O) was consistently less than 
control values, particularly on day 6, when actual DNA content was 
highest in CDGF-injected sponges (data not shown, see Fig. 10). 
ration per microgram DNA (dpm/ug DNA, Fig. 14) fell below 
control values on all four days of the experiment, particularly 
day 6, when relative sponge DNA content was much higher 
than  in  controls (data  not shown,  see  Fig.  10).  This  result 
suggests that although CDGF has potent mitogenic properties 
in vitro, these are masked by recruitment of new mesenchy- 
mat cells to the site of injection in vivo. Unlike the growth- 
limiting conditions used to assess the effects of CDGF in cell 
culture, granulation tissues may be proliferating at maximal 
rates in the absence of growth factor. 
The morphological observations supported the positive mi- 
togenic effect of CDGF on flbroblasts and capillary endothe- 
lial cells,  but CDGF appeared to be involved in local recruit- 
ment of cells to sites  of wound repair.  It is  interesting that 
CDGF elicited effects similar to those produced by cartilage 
powder incorporated into sponge implants  (21).  CDGF ex- 
erted two principal effects on sponge morphology: increased 
vascularity without  increased  inflammation,  and  the  more 
complete organization and infiltration  by fibroblasts of the 
sponge interior.  These findings agree with the positive effect 
of CDGF on capillary endothelial cell motility in vitro (22). 
The  observed  lack  of an  inflammatory response  to  CDGF 
further supports the concept of a direct effect on granulation 
tissue rather than an effect mediated through inflammatory 
cells.  Because  of the  short retention  yet potent  capacity of 
CDGF to organize connective tissue, it is likely that a slowly 
released  version of CDGF can be used as a  wound healing 
accelerator or vulnerary agent. 
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Note Added  in  Proof  Recent  results  indicate  that  CDGF has 
potent  fibroblast  chemotactic  activity  (Senior,  R.  M.,  and  J.  M. 
Davidson, unpublished results). Studies that use brain extracts (Bun- 
trock, P., K. D. Jentzsch, and G. Heder,  1982, Exp. PathoL, 26:46- 
53; Buntrock, P., K. D. Jentzsch, and G. Heder,  1982, Exp. PathoL, 
26:62-67; Buntrock,  P.,  M.  Buntrock,  I.  Marx,  D.  Kranz,  K.  D. 
Jentzsch,  and  G.  Heder,  1984, Exp.  Pathol., 26:247-254)  suggest 
similar properties for another growth factor. 
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